This sponsor

Independent sponsorVerified sponsor· US
Observed deals
3
Principals
2
Latest deal
Aug 2025
As of · the mandate; 14 observations on record

The sponsor's name, 12 additional capital, identity and service provider links, 2 verified contacts (1 email, 1 phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Who they are
3 people named
What they buy (claimed)
EBITDA $4M to $35M
add on, control, founder family, succession
As the firm states it, not checked against its deals.
What they have done
3 observed deals · latest Aug 2025
1 platform, 2 add-ons
Healthcare services, Business services, Manufacturing, Consumer services
3 deals, too few with a known size to say
Portfolio
  • 180 Innovations
  • Zewa Medical Technologies
Who finances them
Equity partners: a partner
Who to call
a named professional
Reveal a line (email and direct phone on record)
Latest: Deal, Aug 2025
Key people
2 people · 1 with a confirmed email · 2 with a direct phone

ranked by who matters most in a conversation with this firm

  • Managing Partner
    Investment

    Managing Partner, the firm's investment decision-maker

    • Confirmed professional email available
    • Direct professional line available
  • Partner
    Investment

    Partner, a senior member of the deal team

    • Direct professional line available

1 confirmed professional email and 2 direct lines for the people at this firm

Each one published by the firm or verified, never a guessed pattern, with the page it came from.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Why this kind
  • for: 3 announced transactions as buyer
What they claim, and what they have done
Observed
  • 1 platform or control deal, Jul 31, 2023 to Jul 31, 2023
  • 2 add-ons bought by its portfolio companies
  • 0 recapitalizations, 0 minority stakes
  • Platform targets by state: IL 1
Claimed on its own website
  • Sectors: Industrial manufacturing, Business services, Consumer services, Healthcare services
  • EBITDA: $4M to $35M
  • Revenue: $20M to $250M, $40M to $400M
  • Geography (unaudited quote): North America
  • Control (unaudited quote): yes
  • Founder or family owned (unaudited quote): yes
  • Add-ons (unaudited quote): yes
Portfolio, as listed on the firm's site (2)
  • Zewa Medical Technologies
  • 180 Innovations
The firm's own listing, not an observed transaction: no date, structure or counterparty is claimed.
What the filings and deals add up to
Sectors transacted
Specialty distribution (3)
Factvertical of the acquired targets· 85%· DFX's own graph
How do we know

Verified sponsor. Evidence identifies a firm: a publisher named it as the buyer in an announced transaction, a law firm or capital partner page names it as an independent sponsor, or its own site says so.

Nothing on this page comes from a website claim unless it is labelled as such with the URL.

Who has financed them
Observed once
Financing, deal by deal
DateCompanyFinanced byRoleAmountSource
Jul 31, 2023Veridian Healthcare LLC
Specialty distribution, IL
a capital providerco sponsorNot disclosedno URL
Service provider relationships

5 more facts and signals are on record for this page. They name the firms involved and open with Independent Sponsor Intelligence.

Legal (3)
Who finances deals like theirs

DFX has not observed these firms together on any transaction in our coverage. That is a statement about what DFX has read, not about the firms: a deal that was never announced, or announced without naming its capital, cannot appear here.

Coverage behind this list: 3 providers observed financing sponsors in this sector · 3 of this firm's own deals read in them · most recent of theirs observed Jan 29, 2025.

  • Peninsula Capital Partners, L.L.C.Specialty distribution7 deals in specialty distribution, latest Oct 15, 2022
    seen as co sponsor, equity coinvest, equity provider, lender
  • Midwest Mezzanine FundsSpecialty distribution5 deals in specialty distribution, latest Jan 29, 2025
    seen as equity coinvest, equity provider, lender, mezzanine
  • Merit Capital PartnersSpecialty distribution4 deals in specialty distribution, latest Feb 1, 2022
    seen as equity coinvest, equity provider, lender, mezzanine

Read from the sectors this firm has actually bought in: specialty distribution (3).

What have they done
Platform and control deals (1)
  1. Jul 31, 2023Platform acquisitionconfidence 80%
    this sponsor acquired Veridian Healthcare LLC (Gurnee, IL)
    EisnerAmper LLP · Advisora capital provider · Co sponsorHolland & Knight LLP · CounselDentons US, LLP · CounselShumaker, Loop & Kendrick, LLP · CounselWilliam Blair & Company, L.L.C. · Sellside advisor
    Deal team: 5 firms · DFX analyst research (General-assisted, every claim URL-cited) no URL · unitedwestern.com unitedwestern.com · hklaw.com hklaw.com · prnewswire.com prnewswire.com · unitedwestern.com unitedwestern.com
Add-ons (2)
  1. Aug 22, 2025Add onconfidence 92%
    this sponsor acquired 180 Innovations, LLC (Denver, CO)
    Holland & Hart LLP · Sellside advisor
    Deal team: 1 firm · DFX analyst research (General-assisted, every claim URL-cited) no URL · unitedwestern.com unitedwestern.com · hollandhart.com hollandhart.com
  2. Sep 4, 2024Add onconfidence 93%
    this sponsor acquired Zewa, Inc.
    Deal page · DFX analyst research (General-assisted, every claim URL-cited) no URL · unitedwestern.com unitedwestern.com · prnewswire.com prnewswire.com
No vehicles linked.
  1. Jul 31, 2023Acquisition announced
    DFX analyst research (General-assisted, every claim URL-cited) no URL
What appears to be their current activity

No vehicle filed in the last 12 months.

Principals, from the firm's own site
  • UnnamedPartner
  • a named professionalManaging Partner
Team, as the firm lists it
  • Colby SladeAnalyst
Who to call
the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts
The firm's published line
Revealable: 1 business phone (the firm's own page), 1 website (sponsor website), 2 work emails (sponsor website), 1 contact form (sponsor website) · as of 2026-09-24
  • a named professional
    Managing Partner · Revealable: 1 business phone (the firm's own page)
  • Partner · Revealable: 1 business phone (the firm's own page)
  • Colby Slade
    Analyst · Revealable: 1 business phone (the firm's own page)

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Portfolio companies (3)
Evidence
FactValueClassSource
Entity kindIndependent sponsor firmFact sbia.org
Entity kindIndependent sponsor firmInferenceDFX model output (scores, estimates, matches) no URL
Entity kindUnknown investment entityInferenceDFX model output (scores, estimates, matches) no URL
Sponsor classificationIndependent sponsor firmFact sbia.org
Stated portfolio2 listed: Zewa Medical Technologies; 180 InnovationsFactIndependent sponsor firm websites (the firm's own contact and team pages) no URL

2 further observations are on the record behind these, each with its own source and date. Ask and we will send the lot.

Email me when this firm changes
No password, no account. One line per change, with the source.
Is this your firm? Correct this recordWork at This sponsor, or see something wrong? Tell us and a person reads it.
Nothing you send is published automatically. A person reads it.
Across the graphs

This sponsor is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Ask DFX